Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM)

83 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,520,480 shares of 22,107,985 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include BML Capital Management, LLC (1,966,000 shares), FRANKLIN RESOURCES INC (1,760,052 shares), VR Adviser, LLC (1,467,048 shares), BlackRock Inc. (1,409,441 shares), Frazier Life Sciences Management, L.P. (1,069,244 shares), VANGUARD GROUP INC (1,009,459 shares), FMR LLC (637,509 shares), Assenagon Asset Management S.A. (617,910 shares), 5AM Venture Management, LLC (541,666 shares), and GEODE CAPITAL MANAGEMENT, LLC (455,787 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.